There are 119 resources available
Clinical activity of DNA PKi single agent and combination therapies
Presenter: Alberto Hernando Calvo
Session: Patient selection for synthetic lethality trials
Resources:
Slides
Webcast
Patient selection for single agent ATRi in the clinic
Presenter: Johann de Bono
Session: Patient selection for synthetic lethality trials
Resources:
Slides
Webcast
Optimal dose, schedule and patient selection for ATRi and PARPi combinations
Presenter: Maria Koehler
Session: Patient selection for synthetic lethality trials
Resources:
Slides
Webcast
Mechanisms of action of ADCs: Preclinical and clinical
Presenter: Guillaume Montagnac
Session: Antibody-drug conjugates (ADCs)
Resources:
Slides
Webcast
Live Q&A and discussion
Presenter: Timothy Yap
Session: Patient selection for synthetic lethality trials
Resources:
Webcast
Current state of the art on ADC therapeutic strategies
Presenter: Aditya Bardia
Session: Antibody-drug conjugates (ADCs)
Resources:
Slides
Webcast
Live conclusions: Can we move towards personalised ADCs?
Presenter: Aditya Bardia
Session: Antibody-drug conjugates (ADCs)
Resources:
Webcast
A glimpse to the future: Moving towards combinations
Presenter: Joshua Drago
Session: Antibody-drug conjugates (ADCs)
Resources:
Slides
Live TAT 2022 highlights
Presenter: Anastasios Stathis
Session: Take home messages and close
Resources:
Slides
Webcast